National Center for Environmental Health/Agency for Toxic Substances and Disease Registry; Teleconference, 50064-50065 [E6-14032]

Download as PDF 50064 Federal Register / Vol. 71, No. 164 / Thursday, August 24, 2006 / Notices Miller, Urbandale, Iowa; and Heidi Loverude, Urbandale, Iowa, acting as a group in concert, to retain voting shares of Freedom Holdings Company, and thereby indirectly retain voting shares of Freedom Financial Bank, both of West Des Moines, Iowa. B. Federal Reserve Bank of St. Louis (Glenda Wilson, Community Affairs Officer) 411 Locust Street, St. Louis, Missouri 63166-2034: 1. Lori and Craig Glattly, both of Lake Forest, Illinois; to acquire shares of Texico Bancshares Corporation, and thereby indirectly acquire voting shares of Texico State Bank, both of Texico, Illinois 2. Dearmin Investment Holdings Business, L.P., Odon, Indiana; to acquire voting shares of Dearmin Bancorp, Inc., and thereby indirectly acquire voting shares of The First National Bank of Odon, both of Odon, Indiana. Board of Governors of the Federal Reserve System, August 21, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6–14066 Filed 8–23–06; 8:45 am] BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM rmajette on PROD1PC67 with NOTICES1 Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank VerDate Aug<31>2005 15:15 Aug 23, 2006 Jkt 208001 holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 18, 2006. A. Federal Reserve Bank of Boston (Richard Walker, Community Affairs Officer) P.O. Box 55882, Boston, Massachusetts 02106-2204: 1. Hampden Bancorp, Inc., Springfield, Massachusetts; to become a bank holding by acquiring 100 percent of the voting shares of Hampden Bank, Springfield, Massachusetts, upon its reorganization from mutual to stock form. B. Federal Reserve Bank of Richmond (A. Linwood Gill, III, Vice President) 701 East Byrd Street, Richmond, Virginia 23261-4528: 1. Congaree Bancshares, Inc., West Columbia, South Carolina; to become a bank holding company by acquiring 100 percent of the voting shares of Congaree State Bank, West Columbia, South Carolina (in organization). C. Federal Reserve Bank of Atlanta (Andre Anderson, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309: 1. Cornerstone Bancorp, Inc., St. Petersburg, Florida; to become a bank holding company by acquiring 100 percent of the voting shares of Cornerstone Community Bank, Saint Petersburg, Florida. Board of Governors of the Federal Reserve System, August 21, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6–14067 Filed 8–23–06; 8:45 am] obtained by the Office of Research Integrity (ORI) during its oversight review of the CCF Report, the U.S. Public Health Service (PHS) found that Kui Zhu, Ph.D., former postdoctoral fellow, CCF, engaged in misconduct in science by intentionally and knowingly fabricating and falsifying data for figures in two publications and with research funded by National Cancer Institute (NCI), National Institutes of Health (NIH), grants R21 CA84038, R01 CA76204, and T32 CA09056. ORI has implemented the following administrative actions for a period of three (3) years, beginning June 7, 2006: (1) Dr. Zhu is debarred from any contracting or subcontracting with any agency of the United States Government and from eligibility or involvement in nonprocurement programs of the United States Government as defined in the debarment regulations at 45 CFR part 76; and (2) Dr. Zhu is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E6–14054 Filed 8–23–06; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–S Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center for Environmental Health/Agency for Toxic Substances and Disease Registry; Teleconference Office of the Secretary Findings of Misconduct in Science Office of the Secretary, HHS. Notice. AGENCY: ACTION: SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant Secretary for Health have taken final action in the following case: Kui Zhu, Ph.D., Cleveland Clinic Research Foundation: Based on accumulated evidence including the Cleveland Clinic Research Foundation (CCF) investigation report (CCF Report) and additional analysis and information PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Agency: The Program Peer Review Subcommittee of the Board of Scientific Counselors (BSC), Centers for Disease Control And Prevention (CDC), National Center for Environmental Health/ Agency for Toxic Substances and Disease Registry (NCEH/ATSDR). In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC, NCEH/ATSCR announces the following subcommittee meeting: Name: Program Peer Review Subcommittee (PPRS). Time and Date: 10 a.m.–12 p.m. Eastern Daylight Savings Time, September 11, 2006. Place: The teleconference will originate at NCEH/ATSDR in Atlanta, Georgia. To E:\FR\FM\24AUN1.SGM 24AUN1 Federal Register / Vol. 71, No. 164 / Thursday, August 24, 2006 / Notices participate, dial 877/315–6535 and enter conference code 383520. Purpose: Under the charge of the BSC, NCEH/ATSDR, the PPRS will provide the BSC, NCEH/ATSDR with advice and recommendations on NCEH/ATSDR program peer review. They will serve the function of organizing, facilitating, and providing a longterm perspective to the conduct of NCEH/ ATSDR program peer review. Matters to be Discussed: A review of the minutes from the previous meeting; a discussion to finalize members of the Peer Review Workgroup for the site specific activities’ peer review, external partners and customers, and chairperson(s); a discussion on the revised schedule for program peer reviews; a discussion of Terrorism Preparedness and Emergency Response Peer Review in February 2007. Agenda items are subject to change as priorities dictate. Supplementary Information: Public comment period is scheduled for 11:20–11:30 a.m. For Further Information Contact: Sandra Malcom, Committee Management Specialist, Office of Science, NCEH/ATSDR, M/S E–28, 1600 Clifton Road, NE., Atlanta, Georgia 30333, telephone 404/498–0622. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and NCEH/ATSDR. Dated: August 18, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–14032 Filed 8–23–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rmajette on PROD1PC67 with NOTICES1 Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 71 FR 44298–44300, dated August 4, 2006) is amended to reflect the transfer of functions and name change to Office of Equal Employment Opportunity, Office of the Director, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: VerDate Aug<31>2005 15:15 Aug 23, 2006 Jkt 208001 Under item (7) of the functional statement for the Office of the Chief Operating Officer (CAJ), delete the following: alternative dispute resolution activities. Delete in its entirety the title and functional statement for the Office of Equal Employment Opportunity (CAV), and insert the following: Office of Dispute Resolution and Equal Employment Opportunity (CAV). The Office of Dispute Resolution and Equal Employment Opportunity (ODREEO) is located in the Office of the Director, Centers for Disease Control and Prevention (CDC). The Director, ODREEO, serves as the principal advisor to the Director, CDC, on all equal employment opportunity matters. The ODREEO: (1) Develops and recommends for adoption CDC-wide equal employment opportunity policies, goals, and priorities to carry out the directives of the U.S. Office of Personnel Management, U.S. Equal Employment Opportunity Commission, and Department of Health and Human Services (DHHS) equal employment opportunity policies and requirements that are mandated by Title VII, Civil Rights Act of 1964; Age Discrimination in Employment Act (ADEA); Rehabilitation Act of 1973; Civil Service Reform Act; 29 CFR 1614, Federal Sector Equal Employment Opportunity; Executive Order 11478, Equal Employment Opportunity in the Federal Government; (2) provides leadership, direction, and technical guidance to CDC managers and staff for the development of comprehensive programs and plans; (3) coordinates and evaluates agency equal employment opportunity operations and plans, including affirmative action; (4) develops plans, programs, and procedures to assure the prompt receipt, investigation, and resolution of complaints of alleged discrimination by reason of race, sex, age, religion, national origin, handicap, or by reason of reprisal or retaliation; (5) coordinates the development of comprehensive special emphasis programs to assure full recognition of the needs of women, Hispanics, other minorities and the handicapped in hiring and employment; (6) identifies needs for ODREEO functions within CDC and assures the development of a training curriculum for all CDC supervisory personnel; (7) prepares or coordinates the preparation of, reports and analyses designed to reflect the status of employment of women and minorities at CDC and maintains liaison with DHHS and other organizations concerned with equal employment opportunity; (8) ensures effective coordination of ODREEO PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 50065 activities with CDC personnel and training programs, and with CDC national centers manpower planning and support programs in the health professions; (9) develops a system of structured reviews and evaluations of CDC ODREEO activities to assure effective operations and accountability; (10) assists in assuring the adequate allocation of resources for ODREEO including the establishment of guidelines for recruiting, selection, and training of agency personnel; (11) develops and directs research and evaluation studies to focus on, and improve the effectiveness of, ODREEO program activities; (12) provides direction for the agency’s alternative dispute resolution activities, and (13) provides direct support for ODREEO program activities in CDC. Dated: August 14, 2006. William H. Gimson, Chief Operating Officer, Centers for Disease Control and Prevention (CDC). [FR Doc. 06–7117 Filed 8–23–06; 8:45 am] BILLING CODE 4160–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Updated Vaccine Information Statements for Influenza Vaccines; Revised Instructions for Use of Vaccine Information Statements Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: SUMMARY: Under the National Childhood Vaccine Injury Act (NCVIA) (42 U.S.C. 300aa–26), the CDC must develop vaccine information materials that all health care providers are required to give to patients/parents prior to administration of specific vaccines. Since January 1, 2006, use of trivalent influenza vaccine information materials has been required. This notice announces availability of updated influenza vaccine information materials for use in the upcoming 2006–07 influenza season. DATES: Each health care provider who administers any trivalent influenza vaccine to any child or adult in the United States during the 2006–07 influenza season shall provide copies of the relevant influenza vaccine information materials referenced in this notice, dated June 30, 2006, to the patient/parent/legal representative in conformance with the June 30, 2006 E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 71, Number 164 (Thursday, August 24, 2006)]
[Notices]
[Pages 50064-50065]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-14032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Environmental Health/Agency for Toxic 
Substances and Disease Registry; Teleconference

    Agency: The Program Peer Review Subcommittee of the Board of 
Scientific Counselors (BSC), Centers for Disease Control And Prevention 
(CDC), National Center for Environmental Health/Agency for Toxic 
Substances and Disease Registry (NCEH/ATSDR).
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC, NCEH/ATSCR announces the following 
subcommittee meeting:

    Name: Program Peer Review Subcommittee (PPRS).
    Time and Date: 10 a.m.-12 p.m. Eastern Daylight Savings Time, 
September 11, 2006.
    Place: The teleconference will originate at NCEH/ATSDR in 
Atlanta, Georgia. To

[[Page 50065]]

participate, dial 877/315-6535 and enter conference code 383520.
    Purpose: Under the charge of the BSC, NCEH/ATSDR, the PPRS will 
provide the BSC, NCEH/ATSDR with advice and recommendations on NCEH/
ATSDR program peer review. They will serve the function of 
organizing, facilitating, and providing a long-term perspective to 
the conduct of NCEH/ATSDR program peer review.
    Matters to be Discussed: A review of the minutes from the 
previous meeting; a discussion to finalize members of the Peer 
Review Workgroup for the site specific activities' peer review, 
external partners and customers, and chairperson(s); a discussion on 
the revised schedule for program peer reviews; a discussion of 
Terrorism Preparedness and Emergency Response Peer Review in 
February 2007.
    Agenda items are subject to change as priorities dictate.
    Supplementary Information: Public comment period is scheduled 
for 11:20-11:30 a.m.
    For Further Information Contact: Sandra Malcom, Committee 
Management Specialist, Office of Science, NCEH/ATSDR, M/S E-28, 1600 
Clifton Road, NE., Atlanta, Georgia 30333, telephone 404/498-0622.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and NCEH/ATSDR.

    Dated: August 18, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-14032 Filed 8-23-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.